Brief Summary (Kısa Özet)The purpose of this study is to evaluate the safety and efficacy of a cerebral oximetry-guided low fraction of inspired oxygen (FiO\_2) ventilation strategy compared to a standard high FiO\_2 strategy in patients undergoing elective thoracic surgery requiring one-lung ventilation (OLV).Oxygen toxicity and related postoperative pulmonary complications remain significant risks during thoracic anesthesia. While standard protocols often rely on high inspired oxygen concentrations to maintain peripheral oxygen saturation (SpO\_2), this approach may induce hyperoxia. Conversely, lowering FiO\_2 arbitrarily can increase the risk of hypoxemia or compromise tissue oxygenation. This prospective, parallel-group, 1:1 randomized, single-blind clinical trial aims to safely reduce intraoperative oxygen exposure by using regional cerebral oxygen saturation (rSO\_2) monitoring as a physiological guide.A total of 60 participants aged 18 and older, classified as ASA I-III and scheduled for elective thoracic surgery, will be randomly assigned to one of two arms:Experimental Group (Guided Low FiO\_2 Strategy): Ventilation will be initiated at a low FiO\_2 of 0.5. The FiO\_2 level will not be increased unless peripheral saturation (SpO\_2) falls below 90% or cerebral oxygenation (rSO\_2) drops below 80% of the patient's baseline value.Active Comparator Group (Standard Strategy): Patients will receive conventional anesthesia management, maintaining standard high FiO\_2 levels to keep SpO\_2 above 90% without cerebral oximetry guidance.The primary outcomes to be measured are the incidence of cerebral desaturation during the perioperative period and the incidence of postoperative delirium assessed via the 3D-CAM tool until hospital discharge. Secondary outcomes include intraoperative hemodynamic stability, arterial blood gas parameters (PaO\_2, PaCO\_2, pH, lactate), incidence of hypoxemia, total one-lung ventilation duration, postoperative cognitive dysfunction (POCD), and lengths of stay in both the intensive care unit (ICU) and the hospital.By utilizing real-time non-invasive cerebral oximetry, the study intends to demonstrate a safe ventilation protocol that minimizes oxygen toxicity without compromising cerebral oxygenation or clinical recovery outcomes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Enrollment
60
Patients receive the standard institutional anesthesia protocol where $SpO\_2$ values are strictly maintained above 90%
Following general anesthesia induction, the initial $FiO\_2$ will be set to 0.5. $FiO\_2$ will not be increased unless the patient's pulse oximetry ($SpO\_2$) drops below 90% or regional cerebral oxygen saturation ($rSO\_2$) drops below 80% of its baseline value
Dicle University
Diyarbakır, Eyalet/Yerleşke, Turkey (Türkiye)
Incidence of Postoperative Delirium
Assessed using the 3D-CAM (Confusion Assessment Method) test
Time frame: Postoperative days 1 to 3 (up to hospital discharge)
Incidence of Cerebral Desaturation
Cerebral desaturation monitored via near-infrared spectroscopy (rSO₂, %)
Time frame: Perioperative period (from anesthesia induction to end of surgery, approximately up to 4 hours)
Incidence of Hypoxemia
Incidence of hypoxemia defined as SpO₂ \< 90% during one-lung ventilation (%)
Time frame: During one-lung ventilation (OLV), approximately up to 2 hours
Mean Fraction of Inspired Oxygen (FiO₂)
Mean FiO₂ levels required to maintain adequate oxygenation during one-lung ventilation
Time frame: During one-lung ventilation (OLV), approximately up to 2 hours
Mean Arterial Pressure (MAP)
Intraoperative mean arterial pressure changes monitored via standard non-invasive or invasive blood pressure measurement (mmHg)
Time frame: Intraoperative period, approximately up to 4 hours
Heart Rate (HR)
Intraoperative heart rate changes monitored via standard ECG (beats per minute)
Time frame: Intraoperative period, approximately up to 4 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.